**Core Concept**
The half-life (T 1/2) of a radioactive substance like iodine-131 is a critical concept in nuclear medicine and radiation therapy. It represents the time required for the radioactivity of a substance to decrease by half due to radioactive decay. This concept is essential for calculating the dose and duration of treatment in patients undergoing radioactive iodine therapy for conditions like thyroid cancer.

**Why the Correct Answer is Right**
Iodine-131 is a radioactive isotope of iodine with a half-life of approximately 8 days. This means that every 8 days, the radioactivity of iodine-131 decreases by half. This property makes it an ideal substance for treating thyroid cancer because it can selectively target and destroy cancerous thyroid tissue while minimizing damage to surrounding healthy tissue. The half-life of iodine-131 is a result of its radioactive decay through beta and gamma radiation, which is a characteristic of its nuclear properties.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not accurately reflect the half-life of iodine-131. The actual half-life of iodine-131 is approximately 8 days, not 1 day.
**Option B:** This option is incorrect because it is too long. While iodine-131 does have a relatively long half-life compared to some other radioactive isotopes, its actual half-life is approximately 8 days, not 30 days.
**Option C:** This option is incorrect because it is too short. Iodine-131 has a relatively long half-life, but its actual half-life is approximately 8 days, not 2 days.

**Clinical Pearl / High-Yield Fact**
A key point to remember when working with radioactive isotopes like iodine-131 is that their half-life is a critical factor in determining their therapeutic and diagnostic applications. Understanding the half-life of these substances can help clinicians optimize treatment regimens and minimize side effects.

**Correct Answer: C. 8 days**